Chek Diagnostics Now Shipping A1CNow+ Systems

INDIANAPOLIS, May 8, 2014 /PRNewswire/ — Chek Diagnostics, the U.S.-based
manufacturer of both the CardioChek® brand and the A1CNow family of
point-of-care diagnostic products, announced today that they have started
shipping A1CNow+ systems to their distributor network. Just four months ago,
Chek Diagnostics acquired the A1CNow family of products from Bayer Diabetes

“A1CNow systems are important to healthcare providers and patients worldwide,”
said Robert Huffstodt, President and CEO of Chek Diagnostics. “So, it was
critical for us to facilitate a seamless transition and deliver the products in
a timely manner.”

Ben Irvin, Director of A1CNow Research and Development, was a member of the team
that developed the original A1CNow system in the early 2000s. “All of us in
Sunnyvale, CA, are excited to be part of Chek Diagnostics. Their expertise in
diagnostic device manufacturing, scientific knowhow, and established
distribution network make this affiliation a perfect fit for the A1CNow family
of products. We are also pleased that we were able to retain over 50 of our key
people and that manufacturing and development will continue at the current plant
in Sunnyvale.”

Not only did Chek Diagnostics acquire a high-quality and well-known product
family, the company also purchased a proven manufacturing facility and is
pleased to also employ so many associates that have a deep institutional
knowledge of the A1CNow technology.

“We are delighted to welcome these former Bayer A1CNow employees and their
customers to the Chek Diagnostics family. This has been an extraordinarily fast
and easy transition. We are proud to be shipping product this quickly,”
Huffstodt continued. “We know there is significant pent-up demand for the
A1CNow+, and are pleased to be able to provide product without further delay.”

A1CNow+ empowers healthcare professionals to provide individuals with an
indicator of average blood glucose control for the past 2 to 3 months.

About Chek Diagnostics – Chek Diagnostics is a global provider of point-of-care
diagnostic products to the healthcare industry. Headquartered in Indianapolis,
Indiana, Chek Diagnostics designs, manufactures, and markets products for
distribution in over 120 countries around the world. The company has sales
offices in Europe, Latin America, and the Pacific Rim. Chek Diagnostics’
products include the CardioChek systems and A1CNow point-of-care systems. The
company also offers a variety of single and combination tests for lipids
(cholesterols), glucose, and ketones, as well as the CardioChek Health Risk
Assessment (HRA) software package. For more information, visit

All trademarks used or mentioned in this release are protected by law.

Logo –

SOURCE Chek Diagnostics

Leave a Reply

Fatal error: Call to undefined function show_subscription_checkbox() in /home3/steer/public_html/ on line 95